Short Interest in Notable Labs, Ltd. (NASDAQ:NTBL) Decreases By 19.3%

Notable Labs, Ltd. (NASDAQ:NTBL) was the target of a significant drop in short interest during the month of September. As of September 30th, there was short interest totalling 502,000 shares, a drop of 19.3% from the September 15th total of 622,000 shares. Currently, 9.7% of the shares of the company are sold short. Based on an average daily trading volume, of 80,900 shares, the days-to-cover ratio is currently 6.2 days.

Analyst Upgrades and Downgrades

Separately, JMP Securities cut Notable Labs from an “outperform” rating to a “market perform” rating in a research note on Friday, September 20th.

Notable Labs Price Performance

Notable Labs stock traded up $0.02 during mid-day trading on Friday, reaching $0.40. The company’s stock had a trading volume of 17,217 shares, compared to its average volume of 54,994. The firm’s fifty day moving average price is $0.49 and its two-hundred day moving average price is $0.78. The company has a quick ratio of 2.77, a current ratio of 2.77 and a debt-to-equity ratio of 0.03. Notable Labs has a 12-month low of $0.38 and a 12-month high of $10.08.

Notable Labs (NASDAQ:NTBL) last announced its quarterly earnings results on Wednesday, August 14th. The company reported ($0.55) earnings per share for the quarter. As a group, equities analysts forecast that Notable Labs will post -0.75 earnings per share for the current year.

About Notable Labs

Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment.